Stay updated on Avutometinib Combo in KRAS G12C NSCLC Clinical Trial

Sign up to get notified when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study status updated to Active, not recruiting (revision v3.3.4). A large portion of investigator contact information and names was removed from the page.
    Difference
    9%
    Check dated 2026-01-14T04:15:30.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added a new 'Locations' section listing recruitment sites across Colorado, District of Columbia, Illinois, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Ohio, Pennsylvania, Texas, Virginia, and Washington; revision updated to v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-23T20:40:46.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2. This appears to be a minor metadata update with no changes to study content or displayed details.
    Difference
    0.0%
    Check dated 2025-11-25T11:00:20.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The government funding notice has been removed from the page. All study details, contacts, and locations remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-18T06:59:22.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    No additions or deletions detected; the Study Details page appears unchanged between screenshots.
    Difference
    0.2%
    Check dated 2025-11-03T21:04:56.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Update includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.
    Difference
    3%
    Check dated 2025-10-06T05:29:49.000Z thumbnail image

Stay in the know with updates to Avutometinib Combo in KRAS G12C NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.